Media Summary: Sylvia Plevritis, Stanford University Computational Timothy Yap, MBBS, PhD, FRCP, The University of Texas MD Anderson Terence Friedlander, MD, University of California, San Francisco, CA, discusses the rationale behind novel drug
Optimizing Combination Cancer Therapy Based - Detailed Analysis & Overview
Sylvia Plevritis, Stanford University Computational Timothy Yap, MBBS, PhD, FRCP, The University of Texas MD Anderson Terence Friedlander, MD, University of California, San Francisco, CA, discusses the rationale behind novel drug Thomas Urban Marron, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY, discusses issues in Phase III ... Medical Physics Masters presentation by: Allison Ng Title: Elizabeth Garrett-Mayer, PhD joined the American Society of Clinical
Richard S. Finn, MD, Robin K. (“Katie”) Kelley, MD, and Laura M. Kulik, MD, discuss HCC in this CME/MOC activity titled "Patient ... Stéphane de Botton, MD, PhD, Gustave Roussy Institute, Paris, France, comments on the Thomas Powles, MD, MBBS, MRCP, director, Barts Patient-physician discussions will be pivotal in personalizing
